MONOFERRIC

Peak

ferric derisomaltose

Pharmacosmos
NDAINTRAVENOUSSOLUTION
Approved
Jan 2020
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

(III) hydroxide and derisomaltose, an iron carbohydrate oligosaccharide that releases iron. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin.

Indications (1)

iron deficiency anemia in adult patients:

Loss of Exclusivity

LOE Date
Jun 22, 2036
125 months away
Patent Expiry
Jun 22, 2036

Patent Records (5)

Patent #ExpiryTypeUse Code
10414831
Mar 25, 2029
SubstanceProduct
—
11851504
Mar 25, 2029
SubstanceProduct
—
12030962
Mar 25, 2029
SubstanceProduct
—
8815301
Aug 14, 2029
SubstanceProduct
U-2734
11633489
Jun 22, 2036
U-3594
Company
Pharmacosmos
Pharmacosmos
Denmark - Holbaek
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers